Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 51, 2587-2592, May 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, R.-H.
Right arrow Articles by McCormick, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, R.-H.
Right arrow Articles by McCormick, J. J.

Lack of a Cell Cycle-dependent Strand Bias for Mutations Induced in the HPRT Gene by (±)-7ß,8{alpha}-Dihydroxy-9{alpha},10{alpha}-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene in Excision Repair-deficient Human Cells1

Ruey-Hwa Chen, Veronica M. Maher2 and J. Justin McCormick

Carcinogenesis Laboratory, Departments of Microbiology and Biochemistry, Michigan State University, East Lansing, Michigan 48824-1316

We showed previously that in repair-proficient human cells the location of the premutagenic lesion induced by (±)-7ß,8{alpha}-dihydroxy-9{alpha},10{alpha}-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene (BPDE), namely, the guanine in a G·C base substitution, in mutants derived from cells treated at the beginning of S phase just when the hypoxanthine (guanine) phosphoribosyltransferase gene is replicated, differs significantly from their location in cells treated 12 h prior to the beginning of S phase (early G1 phase) (R-H. Chen et al., Proc. Natl. Acad. Sci. USA, 87: 8680-8684, 1990). This suggests that the cells preferentially remove BPDE adducts from the transcribed strand. We have now determined the kinds and location of independent mutations induced by BPDE in the coding region of the hypoxanthine (guanine) phosphoribosyltransferase gene of synchronized repair-deficient xeroderma pigmentosum cells (XP12BE, complementation group A), treated at S or in G1. Nineteen of 25 mutants derived from S-treated cells and 23 of 28 mutants from G1-treated cells contained base substitutions. Eighty-nine percent of these involved a G·C base pair, primarily G·C -> T·A transversions. This is similar to the kinds of mutations we saw in the repair-proficient cells. However, in contrast to our earlier results, there was no change in strand distribution of premutagenic BPDE lesions. In both populations, ~26% of the base substitutions involving G·C base pairs had the G located in the transcribed strand, 5 of 18 in the S phase mutants, and 5 of 21 in the G1 phase mutants. These results support the hypothesis that the strong strand bias of induced mutations observed in the repair-proficient cells results from preferential repair of BPDE-induced DNA damage from the transcribed strand.

1 This research was supported in part by Department of Health and Human Services Grant CA21253 from the National Cancer Institute.

2 To whom requests for reprints should be addressed, at Carcinogenesis Laboratory, Fee Hall, Michigan State University, East Lansing, MI 48824-1316.

Received 12/21/90. Accepted 3/ 8/91.




This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
S. Mukhopadhyay, D. R. Clark, N. B. Watson, W. Zacharias, and W. G. McGregor
REV1 accumulates in DNA damage-induced nuclear foci in human cells and is implicated in mutagenesis by benzo[a]pyrenediolepoxide
Nucleic Acids Res., November 2, 2004; 32(19): 5820 - 5826.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. Yadollahi-Farsani, D. S. Davies, and A. R. Boobis
The mutational signature of {alpha}-hydroxytamoxifen at Hprt locus in Chinese hamster cells
Carcinogenesis, November 1, 2002; 23(11): 1947 - 1952.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Ide, H. Oda, Y. Nakatsuru, K. Kusama, H. Sakashita, K. Tanaka, and T. Ishikawa
Xeroderma pigmentosum group A gene action as a protection factor against 4-nitroquinoline 1-oxide-induced tongue carcinogenesis
Carcinogenesis, April 1, 2001; 22(4): 567 - 572.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Ide, N. Iida, Y. Nakatsuru, H. Oda, K. Tanaka, and T. Ishikawa
Mice deficient in the nucleotide excision repair gene XPA have elevated sensitivity to benzo[a]pyrene induction of lung tumors
Carcinogenesis, June 1, 2000; 21(6): 1263 - 1265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1991 by the American Association for Cancer Research.